JPH0214038B2 - - Google Patents

Info

Publication number: JPH0214038B2
Authority: JP; Japan
Prior art keywords: cells; hirs; human; animal; approximately
Prior art date: 1982-02-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

JP57019560A

Other languages

English (en)

Japanese (ja)

Other versions

JPS58138395A (ja

Inventor

Kaname Sugimoto

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Hayashibara Seibutsu Kagaku Kenkyujo KK

Original Assignee

Hayashibara Seibutsu Kagaku Kenkyujo KK

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-02-12

Filing date

1982-02-12

Publication date

1990-04-05

1982-02-12 Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK

1982-02-12 Priority to JP57019560A priority Critical patent/JPS58138395A/ja

1983-02-03 Priority to KR1019830000414A priority patent/KR900005860B1/ko

1983-02-10 Priority to IT47689/83A priority patent/IT1167074B/it

1983-02-11 Priority to GB08303870A priority patent/GB2118560B/en

1983-02-11 Priority to FR8302180A priority patent/FR2521588B1/fr

1983-02-14 Priority to CH805/83A priority patent/CH661745A5/fr

1983-08-17 Publication of JPS58138395A publication Critical patent/JPS58138395A/ja

1990-04-05 Publication of JPH0214038B2 publication Critical patent/JPH0214038B2/ja

Status Granted legal-status Critical Current

Links

241001465754 Metazoa Species 0.000 claims description 36
230000028993 immune response Effects 0.000 claims description 18
238000004519 manufacturing process Methods 0.000 claims description 16
210000001124 body fluid Anatomy 0.000 claims description 6
239000010839 body fluid Substances 0.000 claims description 6
239000000411 inducer Substances 0.000 claims description 3
210000004027 cell Anatomy 0.000 description 91
238000000338 in vitro Methods 0.000 description 11
239000000725 suspension Substances 0.000 description 10
238000009792 diffusion process Methods 0.000 description 9
206010028980 Neoplasm Diseases 0.000 description 8
238000000034 method Methods 0.000 description 7
210000001519 tissue Anatomy 0.000 description 7
241000700159 Rattus Species 0.000 description 6
239000002609 medium Substances 0.000 description 6
235000015097 nutrients Nutrition 0.000 description 6
241000699800 Cricetinae Species 0.000 description 5
241000282412 Homo Species 0.000 description 5
238000011580 nude mouse model Methods 0.000 description 5
241000699660 Mus musculus Species 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
230000000694 effects Effects 0.000 description 4
239000012528 membrane Substances 0.000 description 4
230000035755 proliferation Effects 0.000 description 4
210000004881 tumor cell Anatomy 0.000 description 4
210000004102 animal cell Anatomy 0.000 description 3
201000010099 disease Diseases 0.000 description 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
239000003814 drug Substances 0.000 description 3
235000013601 eggs Nutrition 0.000 description 3
230000008105 immune reaction Effects 0.000 description 3
210000004379 membrane Anatomy 0.000 description 3
239000000126 substance Substances 0.000 description 3
238000002054 transplantation Methods 0.000 description 3
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
108010062580 Concanavalin A Proteins 0.000 description 2
241000287828 Gallus gallus Species 0.000 description 2
206010020751 Hypersensitivity Diseases 0.000 description 2
241000711408 Murine respirovirus Species 0.000 description 2
241000699666 Mus <mouse, genus> Species 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
108010047620 Phytohemagglutinins Proteins 0.000 description 2
239000012980 RPMI-1640 medium Substances 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
235000013330 chicken meat Nutrition 0.000 description 2
210000004748 cultured cell Anatomy 0.000 description 2
238000012258 culturing Methods 0.000 description 2
239000002158 endotoxin Substances 0.000 description 2
238000001914 filtration Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007788 liquid Substances 0.000 description 2
238000012423 maintenance Methods 0.000 description 2
235000013372 meat Nutrition 0.000 description 2
239000003226 mitogen Substances 0.000 description 2
210000003200 peritoneal cavity Anatomy 0.000 description 2
239000002504 physiological saline solution Substances 0.000 description 2
230000001885 phytohemagglutinin Effects 0.000 description 2
239000011148 porous material Substances 0.000 description 2
230000001902 propagating effect Effects 0.000 description 2
238000000746 purification Methods 0.000 description 2
230000004044 response Effects 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
241000894007 species Species 0.000 description 2
210000004989 spleen cell Anatomy 0.000 description 2
210000003462 vein Anatomy 0.000 description 2
241000321096 Adenoides Species 0.000 description 1
206010002198 Anaphylactic reaction Diseases 0.000 description 1
206010003445 Ascites Diseases 0.000 description 1
BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
208000023275 Autoimmune disease Diseases 0.000 description 1
241000271566 Aves Species 0.000 description 1
102000016605 B-Cell Activating Factor Human genes 0.000 description 1
108010028006 B-Cell Activating Factor Proteins 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
238000011740 C57BL/6 mouse Methods 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
241000283707 Capra Species 0.000 description 1
241000700198 Cavia Species 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
241000272201 Columbiformes Species 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
241000283086 Equidae Species 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
206010058467 Lung neoplasm malignant Diseases 0.000 description 1
102000008072 Lymphokines Human genes 0.000 description 1
108010074338 Lymphokines Proteins 0.000 description 1
206010025323 Lymphomas Diseases 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
241000700605 Viruses Species 0.000 description 1
210000000683 abdominal cavity Anatomy 0.000 description 1
210000002534 adenoid Anatomy 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
230000007815 allergy Effects 0.000 description 1
230000036783 anaphylactic response Effects 0.000 description 1
208000003455 anaphylaxis Diseases 0.000 description 1
239000000427 antigen Substances 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
229940041181 antineoplastic drug Drugs 0.000 description 1
238000009395 breeding Methods 0.000 description 1
230000001488 breeding effect Effects 0.000 description 1
244000309466 calf Species 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
230000007910 cell fusion Effects 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
230000019522 cellular metabolic process Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000001816 cooling Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
210000002257 embryonic structure Anatomy 0.000 description 1
210000003754 fetus Anatomy 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
230000009610 hypersensitivity Effects 0.000 description 1
229960003444 immunosuppressant agent Drugs 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
238000011534 incubation Methods 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
238000001155 isoelectric focusing Methods 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
229920006008 lipopolysaccharide Polymers 0.000 description 1
201000007270 liver cancer Diseases 0.000 description 1
208000014018 liver neoplasm Diseases 0.000 description 1
201000005202 lung cancer Diseases 0.000 description 1
208000020816 lung neoplasm Diseases 0.000 description 1
210000002751 lymph Anatomy 0.000 description 1
210000001165 lymph node Anatomy 0.000 description 1
239000000203 mixture Substances 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
210000002741 palatine tonsil Anatomy 0.000 description 1
210000004976 peripheral blood cell Anatomy 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
102000040430 polynucleotide Human genes 0.000 description 1
108091033319 polynucleotide Proteins 0.000 description 1
239000002157 polynucleotide Substances 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
238000002203 pretreatment Methods 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
230000006798 recombination Effects 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
238000005185 salting out Methods 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000003307 slaughter Methods 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000000243 solution Substances 0.000 description 1
238000002336 sorption--desorption measurement Methods 0.000 description 1
208000021550 spleen neoplasm Diseases 0.000 description 1
230000003393 splenic effect Effects 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
208000023959 tonsil neoplasm Diseases 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
238000000108 ultra-filtration Methods 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
238000005406 washing Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Biotechnology (AREA)
Public Health (AREA)
Gastroenterology & Hepatology (AREA)
Animal Behavior & Ethology (AREA)
Biophysics (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Microbiology (AREA)
Transplantation (AREA)
General Engineering & Computer Science (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

JP57019560A 1982-02-12 1982-02-12 ヒト免疫応答抑制因子の製造方法 Granted JPS58138395A (ja)

Priority Applications (6)

Application Number	Priority Date	Filing Date	Title
JP57019560A JPS58138395A (ja)	1982-02-12	1982-02-12	ヒト免疫応答抑制因子の製造方法
KR1019830000414A KR900005860B1 (ko)	1982-02-12	1983-02-03	인간의 면역응답 억제인자의 제조방법
IT47689/83A IT1167074B (it)	1982-02-12	1983-02-10	Procedimento per produrre l'agente soppressore di risposta immunitaria nell'uomo e prodotto ottenuto
GB08303870A GB2118560B (en)	1982-02-12	1983-02-11	Process for producing human immune response suppressor
FR8302180A FR2521588B1 (fr)	1982-02-12	1983-02-11	Procede de production de suppresseur de reponse immunitaire humain
CH805/83A CH661745A5 (fr)	1982-02-12	1983-02-14	Application d'un procede a la production de suppresseur de reponse immunitaire humain.

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP57019560A JPS58138395A (ja)	1982-02-12	1982-02-12	ヒト免疫応答抑制因子の製造方法

Publications (2)

Publication Number	Publication Date
JPS58138395A JPS58138395A (ja)	1983-08-17
JPH0214038B2 true JPH0214038B2 (it)	1990-04-05

Family

ID=12002686

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP57019560A Granted JPS58138395A (ja)	1982-02-12	1982-02-12	ヒト免疫応答抑制因子の製造方法

Country Status (6)

Country	Link
JP (1)	JPS58138395A (it)
KR (1)	KR900005860B1 (it)
CH (1)	CH661745A5 (it)
FR (1)	FR2521588B1 (it)
GB (1)	GB2118560B (it)
IT (1)	IT1167074B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS609795B2 (ja) *	1980-12-11	1985-03-13	株式会社林原生物化学研究所	ヒト上皮細胞成長因子の製造方法
JPS63126897A (ja) *	1986-05-02	1988-05-30	Yoshitomi Pharmaceut Ind Ltd	免疫抑制因子

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2016015B (en) *	1978-01-22	1982-05-06	Hayashibara Co	Method of preparing interferon and preparations containing interferon
JPS5729294A (en) *	1980-07-30	1982-02-17	Hayashibara Biochem Lab Inc	Preparation of human insulin
JPS6045848B2 (ja) *	1980-07-31	1985-10-12	株式会社林原生物化学研究所	ヒト成長ホルモンの製造方法

1982
- 1982-02-12 JP JP57019560A patent/JPS58138395A/ja active Granted
1983
- 1983-02-03 KR KR1019830000414A patent/KR900005860B1/ko not_active IP Right Cessation
- 1983-02-10 IT IT47689/83A patent/IT1167074B/it active
- 1983-02-11 GB GB08303870A patent/GB2118560B/en not_active Expired
- 1983-02-11 FR FR8302180A patent/FR2521588B1/fr not_active Expired
- 1983-02-14 CH CH805/83A patent/CH661745A5/fr not_active IP Right Cessation

Also Published As

Publication number	Publication date
GB8303870D0 (en)	1983-03-16
GB2118560B (en)	1985-06-05
KR900005860B1 (ko)	1990-08-13
CH661745A5 (fr)	1987-08-14
KR840003419A (ko)	1984-09-08
JPS58138395A (ja)	1983-08-17
FR2521588A1 (fr)	1983-08-19
FR2521588B1 (fr)	1985-10-25
GB2118560A (en)	1983-11-02
IT8347689A0 (it)	1983-02-10
IT1167074B (it)	1987-05-06

Publication	Publication Date	Title
KR860000897B1 (ko)	1986-07-16	인체 에리트로포이에틴의 제조방법
JPS6030654B2 (ja)	1985-07-17	ヒトコロニ−刺激因子の製造方法
KR860001588B1 (ko)	1986-10-13	인체 우로가스트론의 제조방법
JPS631296B2 (it)	1988-01-12
JPS585671B2 (ja)	1983-02-01	ヒト卵胞刺激ホルモンの製造方法
KR870000238B1 (ko)	1987-02-18	휴먼 유로키나아제의 제조방법
KR860000898B1 (ko)	1986-07-16	인체 융모막성선 자극호르몬(Human Chorionic Gonadotropin)의 제조방법
KR860000894B1 (ko)	1986-07-16	인체 인슐린의 제조방법
JPS6227048B2 (it)	1987-06-12
JPS6045848B2 (ja)	1985-10-12	ヒト成長ホルモンの製造方法
JPH0214038B2 (it)	1990-04-05
JPS5823793A (ja)	1983-02-12	ヒトｔ細胞増殖因子の製造方法
JPS5825440B2 (ja)	1983-05-27	ヒトカルシトニンの製造方法
KR860001576B1 (ko)	1986-10-10	인체 세포증식 촉진활성인자의 제조방법
JPS5825439B2 (ja)	1983-05-27	ヒト副甲状腺ホルモンの製造方法
KR860001591B1 (ko)	1986-10-13	인체 부신피질 자극호르몬의 제법
JPH0214039B2 (it)	1990-04-05
KR890000383B1 (ko)	1989-03-15	인체 t세포 증식인자
KR860001575B1 (ko)	1986-10-10	인체 태반성 락토겐의 제조방법
KR860001589B1 (ko)	1986-10-13	인체 갑상선 자극호르몬의 제조방법
KR830001817B1 (ko)	1983-09-12	타이프ⅱ 인터페론의 제조방법
KR820001174B1 (ko)	1982-06-29	사람 특이성 인터페론의 제조법
JPH028709B2 (it)	1990-02-26
JPH0446928B2 (it)	1992-07-31
JPS6323176B2 (it)	1988-05-16